Ingredients/alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts
alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its saltsCAS 24558-01-8
Is alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts restricted in cosmetics?
alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts is prohibited in EU CosIng, ASEAN, Health Canada, China NMPA, UK OPSS and Brazil ANVISA. Markets not named here hold no entry for it, which is not a clearance.
- CAS
- 24558-01-8
- INCI
- alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts
- Data refreshed
- 2026-10-12
Regulatory status
| Source | Status | Annex / Details | Limit / Conditions | Last updated |
|---|---|---|---|---|
| EU CosIng | prohibited | Annex II | — | — |
| ASEAN | prohibited | Annex II | — | — |
| Health Canada | prohibited | — | — | 10/7/2026 |
| China NMPA | prohibited | — | — | 10/7/2026 |
| UK OPSS | prohibited | — | Source: legislation.gov.uk retained EU Regulation 1223/2009 Annex Ii | 10/5/2026 |
| Brazil ANVISA | prohibited | — | — | 10/7/2026 |
What this means
alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts has regulatory signals in EU CosIng, ASEAN, Health Canada, China NMPA, UK OPSS, Brazil ANVISA. Review the source links above for the official conditions and latest updates.
Recent regulatory changes
No recorded regulatory changes for alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts yet.
Common questions
- Is alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts restricted in EU cosmetics?
- alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts is prohibited in EU cosmetics according to EU CosIng Annex II.
- Is alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts restricted under the ASEAN Cosmetic Directive?
- alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts is prohibited under the ASEAN Cosmetic Directive Annex II.
- Is alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts restricted in Health Canada?
- alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts is prohibited in cosmetics under Health Canada.
- Is alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts restricted in China NMPA?
- alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts is prohibited in cosmetics under China NMPA.
- Is alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts restricted in UK OPSS?
- alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts is prohibited in cosmetics under UK OPSS.
- Is alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts restricted in Brazil ANVISA?
- alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts is prohibited in cosmetics under Brazil ANVISA.
- What is the CAS number for alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts?
- The CAS number for alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts is 24558-01-8.
Check this ingredient in a formula across 11 markets
This page covers one ingredient on its own. Sign up free to check it at your actual concentration, in a full formula, with GHS hazards and per-market verdicts.